Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime

Show other versions (1)

Background: Various responses and different prognosis to specific treatment in different patients from one hand, and importance of IFN-&#947; producer cells on the other hand impressed us to study Tc1. Methods: The study was conducted in Ghaem Medical Center and Bu-Ali Research Institute, Ma...

Full description

Bibliographic Details
Main Authors:	M Mohajery, AA Shamsian, M Mahmoodi
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2007-05-01
Series:	Iranian Journal of Public Health
Subjects:	Glucantime and lymphocyte Tc1
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/3149.pdf&manuscript_id=3149

Similar Items

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime
by: M Mohajery, et al.
Published: (2007-03-01)

A Comparetaive Study on Glucantime and Oral Terbinafine along with Systemic Glucantime on Cutaneous Leishmaniasis
by: Saba Ebrahimian, et al.
Published: (2011-03-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01)

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
by: Simindokht Soleimanifard, et al.
Published: (2017-01-01)

PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS
by: Reyes Alirio Torres, et al.
Published: (2000-05-01)

Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
by: G Sadeghian, et al.
Published: (2011-01-01)

Immunopathology of american cutaneous leishmaniasis. Modulation of MHC class II gene products by Keratinocytes before and after glucantime therapy
by: Claude Pirmez, et al.
Published: (1990-06-01)

The Skin Side Effects of Topical Glucantime in Patients with Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2015-08-01)

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01)

The Effect of Local Allergic Reaction to Intralesional Glucantime on Recovery Course of Cutaneous Leishmaniasis
by: Saman Afkhami-Ardakani, et al.
Published: (2020-04-01)

The Efficacy of Achillea Millefolium Topical Gel Along with Intralesional Injection of Glucantime in the Treatment of Acute Cutaneous Leishmaniasis
by: Fariba Jaffary, et al.
Published: (2012-03-01)

Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime
by: F Ezatkhah, et al.
Published: (2019-01-01)

The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major
by: Fariba Jaffary, et al.
Published: (2014-01-01)

The Efficacy of Intralesional Injection of Glucantime with Mesotherapy for the Treatment of Cutanuos Leishmaniasis in Comparison to Classic Method
by: Zabiholah Shahmoradi, et al.
Published: (2011-03-01)

Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis
by: Masoud Maleki, et al.
Published: (2012-01-01)

Comparison of Th1 and Th2 Responses in Non-Healing and Healing Patients with Cutaneous Leishmaniasis
by: Maryam Shahi, et al.
Published: (2013-05-01)

Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis
by: Sohrab Iranpour, et al.
Published: (2019-03-01)

A Comparison of the Effects of Topical Injection of Glucantime Plus Glycolic Acid 70% and Salicylic Acid 20% with Topical Injection of Glucantime Alone in the Treatment of Acute Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2017-04-01)

Treatment of Glucantim™-Resistant Cutaneous Leishmaniasis Using Combination Therapy of Allopurinol and Trichloroacetic Acid (TCA) 50%; Report of Three Cases
by: Giti Sadeghian, et al.
Published: (2017-01-01)

Ação do Glucantime sobre macrófagos de camundongos
by: Larissa Moreira Siqueira
Published: (2014)

Ação do Glucantime sobre macrófagos de camundongos
by: Larissa Moreira Siqueira
Published: (2014)

Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice
by: M.A. Nilforoushzadeh, et al.
Published: (2008-11-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: M Mohebali, et al.
Published: (2010-09-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Sup-plementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: F Zamani Sorkhroodi, et al.
Published: (2010-09-01)

Report of 103 cases of visceral Leishmaniasis
by: Tabatabaei P
Published: (1999-07-01)

Visceral and cutaneous leishmaniasis in urban area of cartagena: a case report
by: Pinzón-Redondo Hernando, et al.
Published: (2012-06-01)

The Efficacy of Intralesional Meglumine Antimoniate (Glucantime) versus a Combination of Topical Trichloroacetic Acid 50% and Local Heat Therapy by Non-Ablative Radiofrequency on Cutaneous Leishmaniasis Lesions
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2011-12-01)

Basal cell carcinoma superimposed on a cutaneous leishmaniasis lesion in an immunocompromised patient
by: Ali Asilian, et al.
Published: (2012-01-01)

Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice
by: Soheila Molaie, et al.
Published: (2019-02-01)

Factors affecting the antimonial treatment duration rate in patients with cutaneous leishmaniasis: survival analysis model
by: Amir Hamta, et al.
Published: (2020-09-01)

Visceral leishmaniasis in children
by: mandana Rafeey, et al.
Published: (2005-02-01)

Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
by: Mahshid Mostafavi, et al.
Published: (2019-08-01)

Da necessidade de se adotar e divulgar esquemas terapêuticos para tratamento de leishmaniose tegumentar no Paraná It's necessary to adopt and disseminate therapeutic schemes for the treatment of cutaneous leishmaniasis in Paraná State
by: Ueslei Teodoro, et al.
Published: (1991-06-01)

Manifestações clínicas, laboratoriais e a função dos fagócitos em crianças com leishmaniose visceral tratadas com glucantime
by: Cardoso, Vanessa Viana
Published: (2010)

The effect of glucantime™ on the labeling of blood constituents with technetium-99m Efeito do glucantime™ na marcação de constituintes do sangue com tecnécio-99m
by: Cecília Maria Carvalho Xavier Holanda, et al.
Published: (2005-01-01)

In Vitro Study of Leishmanicidal Activity of Biogenic Selenium Nanoparticles against Iranian Isolate of Sensitive and Glucantime-Resistant Leishmania tropica
by: Hossein Mahmoudvand, et al.
Published: (2014-12-01)

Eficacia y toxicidad de los antimoniales pentavalentes (Glucantime y Pentostam) en un modelo animal de leishmaniasis cutánea americana: aplicación de la luminometría.
by: Hector Hernán Henao, et al.
Published: (2004-12-01)

Trypanothione Reductase Gene Mutations in Meglumine Antimoniate Resistant Isolates from Cutaneous Leishmaniasis Patients Using Molecular Dynamics Method
by: Fatemeh FOZONGARI, et al.
Published: (2020-12-01)

Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Saeedeh Farajzadeh, et al.
Published: (2015-03-01)